Gaush Meditech Ltd (HKG:2407)

Market Cap	1.02B -25.6%
Revenue (ttm)	1.58B +6.8%
Net Income	111.65M +12.3%
EPS	0.76 +13.4%
Shares Out	145.33M
PE Ratio	9.19
Forward PE	n/a
Dividend	0.30 (4.48%)
Ex-Dividend Date	Jun 23, 2025

Volume	35,500
Average Volume	23,625
Open	7.05
Previous Close	6.99
Day's Range	7.05 - 7.24
52-Week Range	4.80 - 9.99
Beta	-0.16
RSI	41.35
Earnings Date	Mar 27, 2026

About Gaush Meditech

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, re...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 819
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2407

Financial Performance

In 2024, Gaush Meditech's revenue was 1.43 billion, an increase of 1.58% compared to the previous year's 1.41 billion. Earnings were 92.39 million, a decrease of -46.75%.

Financial numbers in CNY